Serhat Aytug

Summary

Affiliation: SUNY Downstate Medical Center
Country: USA

Publications

  1. ncbi Allograft diabetic nephropathy may progress to end-stage renal disease
    Moro O Salifu
    Departments of Medicine, Surgery and Pathology, State University of New York, Downstate Medical Center, 450 Clarkson Avenue, Box 52, Brooklyn, NY 11203, USA
    Pediatr Transplant 8:351-6. 2004
  2. ncbi Challenges in the diagnosis and management of renal artery stenosis
    Moro O Salifu
    Renal Fellowship Program, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 52, Brooklyn, NY, 11203, USA
    Curr Hypertens Rep 7:219-27. 2005
  3. ncbi Challenges in the diagnosis and management of new-onset diabetes after transplantation
    Moro O Salifu
    SUNY Downstate Medical Center, Department of Medicine, Renal Fellowship Program, 450 Clarkson Avenue, Box 52, Brooklyn, NY 11203, USA
    Curr Diab Rep 5:194-9. 2005
  4. ncbi Relationship between the soluble F11 receptor and markers of inflammation in hemodialysis patients
    Moro O Salifu
    Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA
    J Investig Med 55:115-9. 2007
  5. ncbi Posttransplant diabetes and hypertension: pathophysiologic insights and therapeutic rationale
    Moro O Salifu
    State University of New York Downstate Medical Center, Renal Fellowship Program, 450 Clarkson Avenue, Box 52, Brooklyn, NY 11203, USA
    Curr Diab Rep 8:221-7. 2008
  6. ncbi Long-term outcomes of dual kidney transplantation-a single center experience
    Moro O Salifu
    Division of Nephrology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA
    Clin Transplant 23:400-6. 2009
  7. ncbi Long-term kidney transplant outcome in obese patients in a predominantly African American population
    Ilhan Karabicak
    SUNY Downstate Medical Center, Brooklyn Endocrinology, Crystal Run Healthcare, Middletown, NY, USA
    Clin Transplant 25:E264-70. 2011
  8. ncbi New-onset diabetes after hemodialysis initiation: impact on survival
    Moro O Salifu
    SUNY Downstate Medical Center, Brooklyn, NY, USA
    Am J Nephrol 31:239-46. 2010

Collaborators

  • Samy I McFarlane
  • Eli A Friedman
  • Anna Babinska
  • Muhammad Shakeel
  • Kevin C Abbott
  • Anis Alam
  • Moro O Salifu
  • Amir Hayat
  • Dhiren M Haria
  • Ilhan Karabicak
  • Syed Shah
  • Dale A Distant
  • Nabil Sumrani
  • Rahul M Jindal
  • Fasika Tedla
  • Shari Lewis
  • Barbara G Delano
  • Frank P Hurst
  • Peter L Flom
  • Anatoly Apel
  • Allen J Norin
  • Muhammad Ikram
  • Christine O'Mahony
  • Howon Lee
  • Mahamadu Zimpa
  • Elizabeth Kornecki
  • Preethi Murty
  • Quirine Kolff
  • Olurotimi Badero
  • Preethi V Murty
  • Halim Ghali
  • Anthony D Nicastri
  • Mariana S Markell
  • Bruce G Sommer

Detail Information

Publications8

  1. ncbi Allograft diabetic nephropathy may progress to end-stage renal disease
    Moro O Salifu
    Departments of Medicine, Surgery and Pathology, State University of New York, Downstate Medical Center, 450 Clarkson Avenue, Box 52, Brooklyn, NY 11203, USA
    Pediatr Transplant 8:351-6. 2004
    ..The occurrence of allograft diabetic nephropathy in some, but not all patients, however, suggests that individual genetic variability modulates disease expression...
  2. ncbi Challenges in the diagnosis and management of renal artery stenosis
    Moro O Salifu
    Renal Fellowship Program, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 52, Brooklyn, NY, 11203, USA
    Curr Hypertens Rep 7:219-27. 2005
    ..Angioplasty and surgical interventions should be reserved for patients with preserved kidney size and hemodynamically significant stenosis...
  3. ncbi Challenges in the diagnosis and management of new-onset diabetes after transplantation
    Moro O Salifu
    SUNY Downstate Medical Center, Department of Medicine, Renal Fellowship Program, 450 Clarkson Avenue, Box 52, Brooklyn, NY 11203, USA
    Curr Diab Rep 5:194-9. 2005
    ..In this article, we discuss the epidemiology, risk factors, pathophysiology, clinical course, and therapeutic and diagnostic challenges of this emerging disease...
  4. ncbi Relationship between the soluble F11 receptor and markers of inflammation in hemodialysis patients
    Moro O Salifu
    Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA
    J Investig Med 55:115-9. 2007
    ..In this study, we examined whether sF11R levels were elevated in hemodialysis (HD) patients and correlated with known inflammatory cytokines...
  5. ncbi Posttransplant diabetes and hypertension: pathophysiologic insights and therapeutic rationale
    Moro O Salifu
    State University of New York Downstate Medical Center, Renal Fellowship Program, 450 Clarkson Avenue, Box 52, Brooklyn, NY 11203, USA
    Curr Diab Rep 8:221-7. 2008
    ..This review outlines the pathogenesis, diagnostic workup, and therapeutic rationale for diabetes and hypertension after transplantation...
  6. ncbi Long-term outcomes of dual kidney transplantation-a single center experience
    Moro O Salifu
    Division of Nephrology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA
    Clin Transplant 23:400-6. 2009
    ..In our population, recipients of dECD transplants have acceptable patient and graft survival with kidneys that would have usually been discarded...
  7. ncbi Long-term kidney transplant outcome in obese patients in a predominantly African American population
    Ilhan Karabicak
    SUNY Downstate Medical Center, Brooklyn Endocrinology, Crystal Run Healthcare, Middletown, NY, USA
    Clin Transplant 25:E264-70. 2011
    ..Obese and morbidly obese African American patients should not be excluded from kidney transplantation on the basis of weight alone...
  8. ncbi New-onset diabetes after hemodialysis initiation: impact on survival
    Moro O Salifu
    SUNY Downstate Medical Center, Brooklyn, NY, USA
    Am J Nephrol 31:239-46. 2010
    ..The incidence of new-onset diabetes after initiation of hemodialysis (NODAD) and its impact on survival is not known...